EPCAM and cancer: The CD24−/EpCAM+ cancer stem cell subpopulation was markedly increased in sphere culture (12.97±2.95%), which was significantly reduced by CDDO-Im treatment (2.44±0.58%) (p<0.001), an 81.2% inhibition (Fig. 3B).